Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Covid19 Drug Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04339634
What this trial is testing

Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy

Who this might be right for
COVIDDrug EffectDrug Interaction+1 more
Tabula Rasa HealthCare 12,873
Testing effectiveness (Phase 2)UnknownNCT04846010
What this trial is testing

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

Who this might be right for
Sequelae of; InfectionPost Infection GlomerulonephritisPost-Infectious Peripheral Neuralgia+15 more
All Natural Medicine Clinic, LLC 2,000
Not applicableStudy completedNCT05687877
What this trial is testing

Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)

Who this might be right for
SARS-CoV-2 Infection
AstraZeneca 366
Early research (Phase 1)Study completedNCT04933864
What this trial is testing

COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy

Who this might be right for
SARS-CoV-2
I.M. Sechenov First Moscow State Medical University 60
Not applicableStudy completedNCT05115370
What this trial is testing

Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19

Who this might be right for
Inflammatory DiseaseRheumatoid ArthritisPsoriatic Arthritis+5 more
University of Nottingham 20
Not applicableUnknownNCT04950673
What this trial is testing

Open-label, Post-marketing, Prospective Study to Assess Impact of COVID-19 on Cognitive Function in Patients

Who this might be right for
Cognitive DeclineCognitive DysfunctionBrain Health+2 more
Cognivue, Inc. 1,000
Large-scale testing (Phase 3)WithdrawnNCT05249790
What this trial is testing

Anti-inflammatory Drug Algorithm for COVID-19 Home Treatment

Who this might be right for
COVID-19
Mario Negri Institute for Pharmacological Research
Not applicableLooking for participantsNCT06452095
What this trial is testing

Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition

Who this might be right for
Long COVIDPost Acute Sequelae of COVID-19Post-COVID-19 Condition
University Health Network, Toronto 120
Large-scale testing (Phase 3)WithdrawnNCT04433013
What this trial is testing

Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19

Who this might be right for
COVID-19
Nanyang Technological University
Not applicableUnknownNCT04876885
What this trial is testing

The Future of Viral Communications: Video-Based Health Promotion Strategies for COVID-19 Vaccinations

Who this might be right for
Health PromotionHealth EducationCOVID-19 Vaccines
McMaster University 100
Large-scale testing (Phase 3)UnknownNCT04394208
What this trial is testing

Silymarin in COVID-19 Pneumonia

Who this might be right for
COVID-19Viral Pneumonia Human Coronavirus
Cairo University 50
Early research (Phase 1)Study completedNCT04406194
What this trial is testing

Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions

Who this might be right for
Bioequivalence
Atabay Kimya Sanayi Ticaret A.S. 30
Large-scale testing (Phase 3)Temporarily pausedNCT04341870
What this trial is testing

Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO

Who this might be right for
COVID19SARS-CoV-2 Infection
Assistance Publique - Hôpitaux de Paris 27
Not applicableStudy completedNCT05926518
What this trial is testing

Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients

Who this might be right for
Critical IllnessTherapeutic Drug MonitoringVenous Thromboembolism
Rijnstate Hospital 62
Large-scale testing (Phase 3)Ended earlyNCT04435795
What this trial is testing

Inhaled Ciclesonide for Outpatients With COVID19

Who this might be right for
COVID 19
McGill University Health Centre/Research Institute of the McGill University Health Centre 215
Testing effectiveness (Phase 2)Study completedNCT05567952
What this trial is testing

Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

Who this might be right for
COVID-19
Pfizer 436
Not applicableEnded earlyNCT04796584
What this trial is testing

Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication

Who this might be right for
Multiple Sclerosis
Providence Health & Services 20
Testing effectiveness (Phase 2)Study completedNCT04468009
What this trial is testing

Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma

Who this might be right for
SARS-Associated CoronavirusCovid19SARS-CoV Infection
Hospital de Infecciosas Francisco Javier Muniz 134
Not applicableLooking for participantsNCT06928506
What this trial is testing

Effect of Hi-OxSR for the Treatment of Post COVID Condition

Who this might be right for
Long COVIDPost COVID-19 ConditionPost Acute Sequelae of COVID-19
University Health Network, Toronto 120
Early research (Phase 1)Not Yet RecruitingNCT07156864
What this trial is testing

"Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC After Single Administration to Adult Patients".

Who this might be right for
COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 35
Next Page